Showing results (31-40 of 84) with videos related to
Sort By:
Pageof 9
Acta Oncologica (Stockholm, Sweden)|January 12, 2019
Effect of 5-fluorouracil on cellular response to proton beam in esophageal cancer cell lines according to the position of spread-out Bragg peakHidehiro Hojo, Takeshi Dohmae, Kenji Hotta, et al.International Journal of Clinical Oncology|August 1, 2017
The 5-year outcomes of moderately hypofractionated radiotherapy (66 Gy in 22 fractions, 3 fractions per week) for localized prostate cancer: a retrospective studyYaichiro Hashimoto, Atsushi Motegi, Tetsuo Akimoto, et al.Journal of Clinical Medicine|March 14, 2026
Quality of Life in Japanese Men Treated with Intensity Modulated Radiotherapy for Localized Prostate Cancer: Three-Year Longitudinal Evaluation Using Patient-Reported Outcomes of the Expanded Prostate Index Composite (EPIC)Norio Mitsuhashi, Atsushi Motegi, Hajime Ikeda, et al.Japanese Journal of Clinical Oncology|April 24, 2018
Palliative radiotherapy for breast cancer patients with skin invasion: a multi-institutional prospective observational studyNaoki Nakamura, Jiro Kawamori, Osamu Takahashi, et al.Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|May 1, 2023
Relationship between changes in quality of life and genitourinary toxicity grade after brachytherapy with I-125 alone for localised prostate cancerYaichiro Hashimoto, Atsushi Motegi, Tetsuo Akimoto, et al.Radiation Oncology (London, England)|February 11, 2018
Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced esophageal squamous cell carcinomaYasuhiro Hirano, Masakatsu Onozawa, Hidehiro Hojo, et al.Journal of Radiation Research|May 24, 2018
Late radiological changes after passive scattering proton beam therapy for Stage I lung cancerNaoki Nakamura, Hidehiro Hojo, Kazuya Inoue, et al.Current Oncology (Toronto, Ont.)|August 28, 2024
Detection of HPV DNA in Saliva of Patients with HPV-Associated Oropharyngeal Cancer Treated with RadiotherapyAtsushi Motegi, Shun-Ichiro Kageyama, Yukie Kashima, et al.Clinical Lung Cancer|March 31, 2019
Impact of EGFR Mutation and ALK Translocation on Recurrence Pattern After Definitive Chemoradiotherapy for Inoperable Stage III Non-squamous Non-small-cell Lung CancerMasaki Nakamura, Shun-Ichiro Kageyama, Seiji Niho, et al.Oncotarget|May 30, 2018
Correction: Radiotherapy increases plasma levels of tumoral cell-free DNA in non-small cell lung cancer patientsShun-Ichiro Kageyama, Keiji Nihei, Katsuyuki Karasawa, et al.Pageof 9